Upgrade to SI Premium - Free Trial

AnaptysBio (ANAB) PT Raised to $95 at Piper Sandler

March 31, 2026 9:35 AM
Piper Sandler analyst Yasmeen Rahimi raised the price target on AnaptysBio (NASDAQ: ANAB) to $95.00 (from $67.00) while maintaining an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change